Democritus University of Thrace (DUTH)
Δεδομένα πραγματικού κόσμου στο πολλαπλό μυέλωμα: συγκρίνοντας θεραπευτικές στρατηγικές με την εθνικότητα, την κοινωνικοοικονομική κατάσταση του ασθενούς και άλλων επιδημιολογικών παραμέτρων μέσω μελέτης επιβίωσης και παραγοντικής ανάλυσης
Abstract
dc:descriptionMultiple myeloma (MM) is an incurable B-cell malignancy arising from a postgerminal B cell neoplasm and characterized by clonal proliferation of pathological plasma cells in the bone marrow. It constitutes about 1% of cancers worldwide and is the second most common hematologic malignancy after lymphoma. The mean patients’ age at diagnosis is estimated by approximately 66 to 70 years, with 37% of patients under 65 years of age. In order to study the effects of socioeconomic status on health care, researchers borrowed some of the methods used by social scientists. They concede that health is affected not only by poverty, but also by a larger number of factors such as income, education and occupation.Patients and MethodsWe retrospectively collected data from 223 patients with symptomatic MM that had been diagnosed and treated in our department from January 2005 to December 2019. From an intention to treat (ITT) analysis, 78 patients were considered TE and 145 were considered NTE. Regarding the ethnic origin of the 223 patients with MM, 172 patients were of Greek origin, 39 were Greek Muslim and 12 were of Balkan origin. The statistical tools, which we used was Kaplan-Meier, Cox Regression, non-parametric tests and for the meta-analysis of studies, we used the Mosteller and Bush formula.ResultsIn the present study, low SES was an independent prognostic factor for survival of patients with MM, together with higher ISS stage and high-risk cytogenetics (Hazard Ratio=2.092 95% CI, (1.36-3.2)). The effect of low SES was more evident in patients with a low ISS stage and without poor prognostic features such as high-risk cytogenetics and end-stage renal failure. . The effect of low SES on survival was more evident in elderly NTE patients with MM. In addition, the effect of low SES on survival of patients with MM was blunted over time in our study. Finally, the ethnic origin and area of residence are not important factors for survival of patients with MM.In meta-analysis, we included 85198 patients with myeloma, and synthesis of H.R. studies shows that high SES myeloma patients have 1,26 (95% CI 1,13-1,31) more probabilities to be alive at five years compared to low SES patients. Regarding studies that included p value and SES, we demonstrated that SES remains a significant prognostic factor for overall survival in myeloma patients globally (p-value of <0,0001).Clinical PointsIn summary, SES in our real world data was an independent prognostic survival factor for patients with MM, together with higher ISS stage and high-risk cytogenetics, and the effect of low SES on survival of patients with MM was blunted over time in our study. Finally, the effect of low SES was more evident in patients with a low ISS stage and without poor prognostic features such as high-risk cytogenetics and end-stage renal failure.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Intzes, Stergios
- Ιντζές, Στέργιος
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/53204